Does waiting time for radiotherapy affect local control of T1N0M0 glottic laryngeal carcinoma?

被引:53
|
作者
Brouha, XDR
Op de coul, B
Terhaard, CHJ
Hordijk, GJ
机构
[1] Univ Med Ctr Utrecht, Dept Otorhinolaryngol, NL-3508 GA Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Radiotherapy, NL-3508 GA Utrecht, Netherlands
[3] Univ Nijmegen Hosp, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands
关键词
laryngeal cancer; radiotherapy; waiting time;
D O I
10.1046/j.1365-2273.2000.00347.x
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
This is a retrospective study of 362 patients with a T1N0M0 glottic laryngeal carcinoma treated by radiotherapy. Waiting time was defined as time from the day of histopathological diagnosis to the first day of radiotherapy. The Cox regression model was used to analyse the influence of waiting time for radiotherapy on the incidence of recurrence. The median follow-up time was 4.4 years. The median waiting time for radiotherapy was 43 days. Local recurrences were found in 58 patients. There was no significant correlation (P = 0.88) between waiting time and the outcome of early glottic cancer as analysed by Cox regression. This retrospective study did not demonstrate an effect of waiting time for radiotherapy on the outcome of early glottic laryngeal cancer.
引用
下载
收藏
页码:215 / 218
页数:4
相关论文
共 50 条
  • [21] FACTORS INFLUENCING SURVIVAL AND PROGNOSIS IN EARLY BREAST CARCINOMA (T1N0M0)
    D'Addetta, C.
    Latiano, T. P.
    Capotorto, A. M.
    Lombardi, L.
    Murgo, R.
    Valori, V. M.
    Parrella, P.
    Copetti, M.
    Maiello, E.
    CANCER TREATMENT REVIEWS, 2010, 36 : S99 - S100
  • [22] PREDICTORS OF RECURRENCE IN STAGE I (T1N0M0) BREAST-CARCINOMA
    ROSEN, PP
    SAIGO, PE
    BRAUN, DW
    WEATHERS, E
    DEPALO, A
    ANNALS OF SURGERY, 1981, 193 (01) : 15 - 25
  • [23] Nutritional and clinical outcomes of chemoradiotherapy for clinical T1N0M0 esophageal carcinoma
    Sakanaka, Katsuyuki
    Fujii, Kota
    Ishida, Yuichi
    Miyamoto, Shin'ichi
    Horimatsu, Takahiro
    Muto, Manabu
    Mizowaki, Takashi
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 3623 - 3630
  • [24] Pulmonary adenocarcinoma T1N0M0 and its classification
    Weissferdt, Annikka
    Walsh, Garrett
    Kaiser, Larry
    Moran, Cesar A.
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2014, 31 (04) : 260 - 264
  • [25] RADIOTHERAPY OR SURGERY FOR T2N0M0 GLOTTIC CARCINOMA - A DECISION-ANALYTIC APPROACH
    STALPERS, LJA
    VERBEEK, ALM
    VANDAAL, WAJ
    RADIOTHERAPY AND ONCOLOGY, 1989, 14 (03) : 209 - 217
  • [26] Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery
    Spector, JG
    Sessions, DG
    Chao, KSC
    Hanson, JM
    Simpson, JR
    Perez, CA
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1999, 21 (02): : 116 - 123
  • [27] Management of Clinical T1N0M0 Esophageal Cancer
    Yang, Andrew J.
    Choi, Seo Hee
    Byun, Hwa Kyung
    Kim, Hyun Ju
    Choi, Jinhyun
    Lee, Yong Chan
    Lee, Sang Kil
    Park, Kyung Ran
    Lee, Chang Geol
    GUT AND LIVER, 2019, 13 (03) : 315 - 324
  • [28] Oncological outcomes of surgical management for T2N0M0 glottic laryngeal squamous cell carcinoma
    Zhou Jian
    Xu Cheng-Zhi
    Zhu Xiao-Ke
    Yang Yue
    Zhou Liang
    Gong Hong-Li
    Tao Lei
    世界耳鼻咽喉头颈外科杂志(英文), 2025, 11 (01)
  • [29] TREATMENT DECISIONS IN T3N0M0 GLOTTIC CARCINOMA
    BRYANT, GP
    POULSEN, MG
    TRIPCONY, L
    DICKIE, GJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (02): : 285 - 293
  • [30] T3N0M0 GLOTTIC CARCINOMA - A FAILURE ANALYSIS
    LUNDGREN, JAV
    GILBERT, RW
    VANNOSTRAND, AWP
    HARWOOD, AR
    KEANE, TJ
    BRIANT, TDR
    CLINICAL OTOLARYNGOLOGY, 1988, 13 (06): : 455 - 465